
Turn Therapeutics
A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.
About
Turn Therapeutics, Inc. is a clinical-stage dermatology company focused on the development of innovative treatments for inflammatory skin conditions. The company aims to address unmet needs in the dermatology market by advancing novel therapeutic candidates through clinical trials.
Key facts
At-a-glance profile data
- Website
- turntherapeutics.com
- Headquarters
- Los Angeles, California, USA
- Founded
- 2019
- Total funding
- $25M (Loan Facility)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Post-money | Lead investors |
|---|---|---|---|---|
| 24 Mar 2026 | Loan Facility | $25M | $101M | - |
Tech stack
Detected on turntherapeutics.com, last scanned 11 Sept 2026. Run your own scan
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has Turn Therapeutics raised?
Turn Therapeutics has raised a total of $25M in funding. The most recent round on record is Loan Facility.
